ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics
ANIP Price/Volume Stats
Current price | $69.13 | 52-week high | $70.81 |
Prev. close | $69.69 | 52-week low | $36.99 |
Day low | $69.00 | Volume | 252,100 |
Day high | $70.05 | Avg. volume | 136,026 |
50-day MA | $61.27 | Dividend yield | N/A |
200-day MA | $57.32 | Market Cap | 1.46B |
ANIP Stock Price Chart Interactive Chart >
ANIP POWR Grades
- Growth is the dimension where ANIP ranks best; there it ranks ahead of 99.81% of US stocks.
- The strongest trend for ANIP is in Growth, which has been heading up over the past 26 weeks.
- ANIP ranks lowest in Momentum; there it ranks in the 6th percentile.
ANIP Stock Summary
- ANIP's current price/earnings ratio is 97.68, which is higher than 93.59% of US stocks with positive earnings.
- In terms of twelve month growth in earnings before interest and taxes, ANI PHARMACEUTICALS INC is reporting a growth rate of -166.71%; that's higher than merely 8.09% of US stocks.
- Revenue growth over the past 12 months for ANI PHARMACEUTICALS INC comes in at 58.75%, a number that bests 92.23% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to ANI PHARMACEUTICALS INC, a group of peers worth examining would be ZBH, GMED, MTX, DHX, and GNRC.
- ANIP's SEC filings can be seen here. And to visit ANI PHARMACEUTICALS INC's official web site, go to www.anipharmaceuticals.com.
ANIP Valuation Summary
- ANIP's EV/EBIT ratio is 29.1; this is 99.32% higher than that of the median Healthcare stock.
- ANIP's price/earnings ratio has moved up 108.3 over the prior 243 months.
Below are key valuation metrics over time for ANIP.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
ANIP | 2023-12-29 | 2.5 | 2.6 | 95.9 | 29.1 |
ANIP | 2023-12-28 | 2.5 | 2.6 | 95.3 | 29.0 |
ANIP | 2023-12-27 | 2.5 | 2.6 | 95.8 | 29.1 |
ANIP | 2023-12-26 | 2.5 | 2.6 | 96.2 | 29.2 |
ANIP | 2023-12-22 | 2.4 | 2.5 | 92.9 | 28.3 |
ANIP | 2023-12-21 | 2.4 | 2.5 | 92.4 | 28.1 |
ANIP Growth Metrics
- The 4 year price growth rate now stands at -32%.
- The 3 year cash and equivalents growth rate now stands at 89.43%.
- Its 3 year net cashflow from operations growth rate is now at -162.1%.
The table below shows ANIP's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 283.082 | -38.988 | -69.197 |
2022-06-30 | 251.322 | -48.013 | -64.638 |
2022-03-31 | 226.092 | -36.288 | -63.414 |
2021-12-31 | 216.136 | 3.322 | -42.793 |
2021-09-30 | 212.459 | 9.798 | -22.102 |
2021-06-30 | 213.377 | 13.586 | -17.221 |
ANIP's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ANIP has a Quality Grade of D, ranking ahead of 9.89% of graded US stocks.
- ANIP's asset turnover comes in at 0.453 -- ranking 96th of 682 Pharmaceutical Products stocks.
- NWBO, CYTR, and NAII are the stocks whose asset turnover ratios are most correlated with ANIP.
The table below shows ANIP's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.453 | 0.570 | -0.047 |
2021-06-30 | 0.457 | 0.592 | -0.029 |
2021-03-31 | 0.460 | 0.600 | -0.018 |
2020-12-31 | 0.446 | 0.582 | -0.047 |
2020-09-30 | 0.427 | 0.596 | -0.063 |
2020-06-30 | 0.425 | 0.619 | -0.054 |
ANIP Price Target
For more insight on analysts targets of ANIP, see our ANIP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $45.00 | Average Broker Recommendation | 1.75 (Moderate Buy) |
ANI Pharmaceuticals, Inc. (ANIP) Company Bio
ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company was founded in 2004 and is based in Baudette, Minnesota.
Latest ANIP News From Around the Web
Below are the latest news stories about ANI PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ANIP as an investment opportunity.
Investing in ANI Pharmaceuticals (NASDAQ:ANIP) three years ago would have delivered you a 59% gainANI Pharmaceuticals, Inc. ( NASDAQ:ANIP ) shareholders have seen the share price descend 23% over the month. But that... |
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare ConferenceBAUDETTE, Minn., Nov. 22, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President & CEO, will participate at the Piper Sandler 35th Annual Healthcare Conference in New York City as follows: Date: Tuesday, November 28, 2023 Time:1:00pm – 1:25pm ET Webcast: Click Here To schedule a 1x1 meeting with the Company, please contact [email protected]. The live and archived webcast will be accessible from the Company’s web |
A Boring Biopharma Can Be a Good BetInvestors have finally seen some long awaited and much needed breadth within the market rally in recent trading sessions. This strategy provides downside protection of approximately 14% during the five-month option duration. |
Insider Sell Alert: SVP, CHIEF HR OFFICER Krista Davis Sells Shares of ANI Pharmaceuticals IncANI Pharmaceuticals Inc (NASDAQ:ANIP) has recently witnessed an insider sell that has caught the attention of investors and market analysts. |
Is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock Price Struggling As A Result Of Its Mixed Financials?With its stock down 20% over the past week, it is easy to disregard ANI Pharmaceuticals (NASDAQ:ANIP). It is possible... |
ANIP Price Returns
1-mo | 14.68% |
3-mo | 25.37% |
6-mo | 19.07% |
1-year | 74.88% |
3-year | 109.87% |
5-year | -2.00% |
YTD | 25.37% |
2023 | 37.06% |
2022 | -12.70% |
2021 | 58.68% |
2020 | -52.91% |
2019 | 36.98% |
Continue Researching ANIP
Want to do more research on Ani Pharmaceuticals Inc's stock and its price? Try the links below:Ani Pharmaceuticals Inc (ANIP) Stock Price | Nasdaq
Ani Pharmaceuticals Inc (ANIP) Stock Quote, History and News - Yahoo Finance
Ani Pharmaceuticals Inc (ANIP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...